Clinical trial for SCID

Dr. Judy Shizuru: Photo courtesy Jasper Therapeutics Over the years, the California Institute for Regenerative Medicine (CIRM) has invested a lot in helping children born with severe combined immunodeficiency (SCID), a fatal immune disorder. And we have seen great results, with some researchers reporting a 95 percent success rate in curing these children. SCID therapy … Continue reading Clinical trial for SCID

Fast Track designation for a therapy making transplants safer for children with a fatal immune disorder

Bone marrow transplant For children born with severe combined immunodeficiency, life is extremely challenging. SCID leaves them without a functioning immune system, so even minor infections can be life‑threatening. Without treatment, many children die within the first few years of life. CIRM-funded clinical trials CIRM‑funded stem cell and gene therapy trials at UCLA and UCSF/St. … Continue reading Fast Track designation for a therapy making transplants safer for children with a fatal immune disorder